Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure

Journal of Thoracic Oncology

Volumn 9, Issue 10, 2014, Pages 1554-1560

  Gomez, Daniel R ^a   Yusuf, Syed Wamique ^a   Munsell, Mark F ^a   Welsh, James W ^a   Liao, Zhongxing ^a   Lin, Steven H ^a   Pan, Hubert Y ^a   Chang, Joe Y ^a   Komaki, Ritsuko ^a   Cox, James D ^a   McAleer, Mary Frances ^a   Grosshans, David R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain natriuretic peptide; Cardiac toxicity; Lung cancer; Radiation therapy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CISPLATIN; ETOPOSIDE; TROPONIN I; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; ECG ABNORMALITY; ELECTROCARDIOGRAM; EXPLORATORY RESEARCH; FOLLOW UP; HEART; HEART FUNCTION; HUMAN; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; R WAVE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; T WAVE; THORAX CANCER; ADVERSE EFFECTS; CLINICAL TRIAL; CONFORMAL RADIOTHERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RADIATION INJURIES; RADIATION RESPONSE; THORACIC NEOPLASMS;

ADULT; AGED; BIOMARKERS, TUMOR; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; THORACIC NEOPLASMS; TROPONIN I;

EID: 84925831265     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000306     Document Type: Article

References (19)

1. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69:1241-1247.
2. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087-2106.
3. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993;270:1949-1955.
4. Lund MB, Ihlen H, Voss BM, et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996;75:591-595.
5. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-998.
6. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-877.
7. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-145.
8. D'Errico MP, Grimaldi L, Petruzzelli MF, et al. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys 2012;82:e239-e246.
9. Hughes-Davies L, Sacks D, Rescigno J, Howard S, Harris J. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol 1995;13:2582-2584.
10. Kozak KR, Hong TS, Sluss PM, et al. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer 2008;62:351-355.
11. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-1965.
12. Latini R, Masson S, Anand IS, et al.; Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-1249.
13. Scharhag J, Urhausen A, Schneider G, et al. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur J Cardiovasc Prev Rehabil 2006;13:388-397.
14. Burjonroppa SC, Tong AT, Xiao LC, Johnson MM, Yusuf SW, Lenihan DJ. Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload. Am J Clin Oncol 2007;30:287-293.
15. Saif MW, Shah MM, Shah AR. Fluoropyrimidine-associated cardiotoxicity: revisited. Expert Opin Drug Saf 2009;8:191-202.
16. Gomez DR, Poenisch F, Pinnix CC, et al. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys 2013;87:570-575.
17. Oshiro Y, Sugahara S, Noma M, et al. Proton beam therapy interference with implanted cardiac pacemakers. Int J Radiat Oncol Biol Phys 2008;72:723-727.
18. Vasic N, Stevic R, Pesut D, Jovanovic D. Acute left bundle branch block as a complication of brachytherapy for lung cancer. Respir Med 2011;105(Suppl 1):S78-S80.
19. MacKenzie R. Poor R-wave progression. J Insur Med 2005;37:58-62.